---
---

@string{aps = {American Physical Society,}}

@article{olivas2025usortm,
  title={uSortM: scalable isolation of user-defined clones from pooled gene libraries},
  author={Olivas*, Micah and Almhjell*, Patrick and Zepezauer, Forrest and Herschlag, Daniel and Fordyce, Polly},
  journal={bioRxiv},
  year={2025},
  selected={true},
  annotation={* denotes equal contributions},
  abstract={Preprint describing uSortM method for scalable clone isolation from pooled gene libraries.},
  preview={usortm-icon.png}
}

@article{han2020crispr,
  title={CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities},
  author={Han, Kyuho and Pierce, Sarah E. and Li, Amy and Spees, Kaitlyn and Anderson, Gray R. and Seoane, Jose A. and Lo, Yuan-Hung and Dubreuil, Michael and Olivas, Micah and others},
  journal={Nature},
  volume={580},
  pages={136--141},
  year={2020},
  selected={true},
  abstract={Cancer genomics studies have identified thousands of putative cancer driver genes1. Development of high-throughput and accurate models to define the functions of these genes is a major challenge. Here we devised a scalable cancer-spheroid model and performed genome-wide CRISPR screens in 2D monolayers and 3D lung-cancer spheroids. CRISPR phenotypes in 3D more accurately recapitulated those of in vivo tumours, and genes with differential sensitivities between 2D and 3D conditions were highly enriched for genes that are mutated in lung cancers. These analyses also revealed drivers that are essential for cancer growth in 3D and in vivo, but not in 2D. Notably, we found that carboxypeptidase D is responsible for removal of a C-terminal RKRR motif2 from the Î±-chain of the insulin-like growth factor 1 receptor that is critical for receptor activity. Carboxypeptidase D expression correlates with patient outcomes in patients with lung cancer, and loss of carboxypeptidase D reduced tumour growth. Our results reveal key differences between 2D and 3D cancer models, and establish a generalizable strategy for performing CRISPR screens in spheroids to reveal cancer vulnerabilities.}
}

@inproceedings{fannjiang2022designing,
  title={Designing active and thermostable enzymes with sequence-only predictive models},
  author={Fannjiang*, Clara and Olivas*, Micah and others},
  booktitle={NeurIPS LMRL Workshop},
  year={2022},
  selected={true},
  annotation={* denotes equal contributions},
  abstract={Data-driven models of protein fitness can be useful in designing novel proteins with improved properties, but many questions remain regarding how and in what settings they should be used. Here, we ask: How can we use predictive models of protein fitness, whose predictions we might not always trust, to design protein sequences enhanced for multiple fitness functions? We propose a general approach for doing so, and apply it to design novel variants of eight different acylphosphatase and lysozyme wild types, intended to be more thermostable and at least as catalytically active as the wild types. Our method does not require a structure, experimental measurements of activity, curation of homologous sequences, or family-specific thermostability data. Experimental characterizations of our designed sequences, as well as sequences designed by PROSS, a competitive baseline method for improving protein thermostability, are currently underway and forthcoming.},
}